Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
OTC Markets OTCPK - Delayed Quote USD

Moberg Pharma AB (publ) (MBGPF)

Compare
0.8200
0.0000
(0.00%)
At close: February 21 at 3:00:00 PM EST
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
9,811
9,811
--
207
--
Cost of Revenue
3,496
3,496
--
--
--
Gross Profit
6,315
6,315
--
207
--
Operating Expense
331,145
331,145
27,463
20,724
19,730
Operating Income
-324,830
-324,830
-27,463
-20,517
-19,730
Net Non Operating Interest Income Expense
4,356
4,356
2,043
715
-240
Pretax Income
-320,474
-320,474
-25,420
-19,512
-19,970
Tax Provision
-65,363
-65,363
-4,327
-3,802
-3,748
Net Income Common Stockholders
-255,111
-255,111
-21,093
-15,710
7,492
Diluted NI Available to Com Stockholders
-255,111
-255,111
-21,093
-15,710
7,492
Basic EPS
-6.74
-6.74
-1.33
-2.07
1.13
Diluted EPS
-6.74
-6.74
-1.33
-2.07
1.13
Basic Average Shares
37,847.7290
37,847.7290
15,871.7990
7,587.1660
6,455.8650
Diluted Average Shares
38,908.8560
38,908.8560
35,520.8990
7,752.3200
6,620.1890
Total Operating Income as Reported
-324,830
-324,830
-27,463
-20,226
-19,730
Total Expenses
334,641
334,641
27,463
20,724
19,730
Net Income from Continuing & Discontinued Operation
-255,111
-255,111
-21,093
-15,710
7,492
Normalized Income
-255,111
-255,111
-21,093
-15,710
-16,097
Interest Income
4,584
4,584
2,303
786
--
Interest Expense
228
228
260
71
129
Net Interest Income
4,356
4,356
2,043
715
-240
EBIT
-320,246
-320,246
-25,160
-19,441
-19,841
EBITDA
-18,927
-18,927
-23,061
-16,859
-17,257
Reconciled Cost of Revenue
3,496
3,496
--
--
--
Reconciled Depreciation
301,319
301,319
2,099
2,582
2,584
Net Income from Continuing Operation Net Minority Interest
-255,111
-255,111
-21,093
-15,710
-16,097
Normalized EBITDA
-18,927
-18,927
-23,061
-16,859
-17,257
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
12/31/2021 - 8/15/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CPHRF Cipher Pharmaceuticals Inc.
8.78
-2.23%
 
HROW Harrow, Inc.
28.95
-3.92%
 
ANIP ANI Pharmaceuticals, Inc.
57.94
-2.90%
 
GLASF Glass House Brands Inc.
6.46
+0.22%
 
ETON Eton Pharmaceuticals, Inc.
14.51
+0.83%
 
CPH.TO Cipher Pharmaceuticals Inc.
12.50
-1.19%
 
PRGO Perrigo Company plc
25.34
+0.40%
 
VRNOF Verano Holdings Corp.
1.0400
0.00%
 
GTBIF Green Thumb Industries Inc.
7.11
+0.14%
 
VTRS Viatris Inc.
11.25
+1.72%